Neurotoxicity of hydroxylated tryptamines: structure-activity relationships. 1. Long-term effects on monoamine content and fluorescence morphology of central monoamine neurons.
D000818:Animals; D001369:Axons / Q000187:drug effects / Q000378:metabolism; D001921:Brain / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D005260:Female; D007276:Injections, Intraventricular; D008856:Microscopy, Fluorescence; D009411:Nerve Endings / Q000187:drug effects / Q000378:metabolism; D009474:Neurons / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism*; D051381:Rats; D012701:Serotonin / Q000378:metabolism*; D013116:Spinal Cord / Q000378:metabolism*; D013997:Time Factors; D014363:Tryptamines / Q000008:administration & dosage / Q000494:pharmacology*
D014363:Tryptamines; D012701:Serotonin; D004298:Dopamine; D009638:Norepinephrine